International Journal of Pharmaceutical and Phytopharmacological Research
ISSN (Print): 2250-1029
ISSN (Online): 2249-6084
Publish with eIJPPR Submission
2021   Volume 11   Issue 1

Role of Glucagon-like peptide-1 “Liraglutide” in Management of Type 1 Diabetes: A review
Download PDF


Abdulrahman Jameel A Sehly, Rayyan Fahad H Altemani, Yousef Hussain J Alharthi, Aminah Ghanem S Alhwiti, Abdulaziz Abdulrahman A Bedaiwi, Waad Maher Alqulayti, Rakan Ahmed I Alshuwaier, Abdulrahman Saleh A Alaql, Ibrahim Mahmoud H Ajwah
Citation
Vancouver
Sehly AJA, Altemani RFH, Alharthi YHJ, Alhwiti AGS, Bedaiwi AAA, Alqulayti WM, et al. Role of Glucagon-like peptide-1 “Liraglutide” in Management of Type 1 Diabetes: A review. Int J Pharm Phytopharmacol Res. 2021;11(1):89-93. https://doi.org/10.51847/SkBDqRo7ng
APA
Sehly, A. J. A., Altemani, R. F. H., Alharthi, Y. H. J., Alhwiti, A. G. S., Bedaiwi, A. A. A., Alqulayti, W. M., Alshuwaier, R. A. I., Alaql, A. S. A., & Ajwah, I. M. H. (2021). Role of Glucagon-like peptide-1 “Liraglutide” in Management of Type 1 Diabetes: A review. International Journal of Pharmaceutical And Phytopharmacological Research, 11(1), 89-93. https://doi.org/10.51847/SkBDqRo7ng
Download citation:   EndNote   RIS
Article Link:
Abstract

Glucagon-like peptide-1 (GLP-1) overpowers glucagon secretion, endorses satiety, postpones gastric draining, and arouses peripheral glucose consumption. This systematic review was carried out including PubMed, Google Scholar, and EBSCO that examined randomized controlled trials, observational, and experimental studies that had studied the role of GLP-1 (liraglutide) in controlling juvenile diabetes. The study included 7 studies and concluded that the introduction of liraglutide to insulin treatment juvenile diabetic patients results in a considerable and fast decrease in glycemic excursions and a consequent reduction in insulin dose. Body weight decreases substantially as reported in many studies.


International Journal of Pharmaceutical and Phytopharmacological Research
© 2022 All rights reserved